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revascularization procedures when compared to VBT for the treatment of ISR. This
beneﬁt does not appear to be associated with a signiﬁcant reduction in mortality or
myocardial infarction.
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Background: 2nd generation drug eluting stent (2nd DES) is known to be different
from 1st generation drug eluting stent (1st DES) in various aspects. So the optimal
strategy to treat in-stent restenosis of 2nd DES could be different from that of 1st DES.
Although most of recent coronary intervention use 2nd DES, there seems to be no
prior report focusing solely on this issue.
Methods: Among patients who received de novo PCI with 2nd DES between 2011 to
2013 in our hospital, there are 47 patients who encountered in-stent restenosis and
then revascularized, and also received follow up coronary angiography 9 month after
the revascularization, the strategy of which was at the operator’s discretion. We
analyze the outcome of the 47 patients retrospectively. Among them, 10 (21%) was
stent edge restenosis, 24 (51%) was focal in-stent restenosis, and 13 (28%) was diffuse
in-stent restenosis. Plain Old Balloon Angioplasty (POBA) was applied to 18 (38%)
patients, another DES was implanted to 29 (62%) patients.
Results: To focal in-stent restenosis, besides POBA therapy result in high re-reste-
nosis rate, another DES implantation signiﬁcantly reduced re-restenosis (0.61 vs 0.09,
P< 0.01). On the other hand, to diffuse in-stent restenosis, POBA and another
DES implantation did not differ signiﬁcantly, whose restenosis rates were 0.25 and
0.44, respectively (p¼0.5). Overall, another DES implantation signiﬁcantly reduced
re-restenosis compared to POBA (0.56 vs 0.17, p< 0.01).
Conclusions: Comparing POBA with another DES implantation as the therapy of 2nd
DES restenosis, POBA results in higher re-restenosis rate compared to another DES
implantation to focal type restenosis. But to diffuse type restenosis, POBA and another
DES implantation do not differ signiﬁcantly in their re-restenosis rates.
TCT-663
Cost Comparisons of Invasive and Non-Invasive Diagnostic Evaluations for
Patients with Suspected In-Stent Restenosis Following Implant of Metallic Stents
and Bioresorbable Scaffolds
James K. Min1, James T. Hasegawa2, Susanne F. Machacz2, Ken O’Day3
1Weill Cornell Medical College, New York, NY, 2Abbott Vascular, Santa Clara, CA,
3Xcenda, Palm Harbor, FL
Background: Presentation with symptoms such as chest pain and angina following
percutaneous coronary intervention (PCI) is not uncommon. These symptoms can be
indicative of in-stent restenosis (ISR), with traditional diagnostic work-up consisting
of invasive coronary angiography (ICA), non-invasive stress imaging, or coronary
computed tomographic angiography (CCTA). At present, the comparative costs of
evaluation strategies by invasive vs. non-invasive methods remain unknown
Methods: We developed a decision analytic model to determine the 2-year costs
for individuals undergoing PCI, measured by downstream costs per patient undergoing
PCI with suspected ISR. Costs included testing costs and costs due to complications of
testing using Medicare reimbursement rates for the United States. PCI was modeled
for both metallic stents and bioresorbable scaffolds (BRS), with stents dichotomized
as vs.< 3.0mm in diameter. An invasive testing strategy consisting of direct referral to
ICA was compared to 2 non-invasive strategies. Non-invasive diagnostic strategies
included CCTA followed by ICA or stress testing by single photon emission computed
tomography (SPECT) followed by ICA for abnormal or indeterminate results.
Results: The overall 2-year costs per patient were equivalent between individuals
undergoing PCI with metallic stents and BRS for an ICA-based strategy (metallic stent:
$1,547, BRS: $1,547) and slightly lower with BRS for a stress testing-based strategy
(metallic stent: $1,221, BRS: $1,206). However, for a CCTA-based strategy, BRS was
associated with lower costs than metallic stents in both < 3.0mm vessels (metallic
stent: $1,133, BRS: $772) and  3.0mm vessels (metallic stent: $1,342, BRS: $431).
Test-related complication rates for testing strategies ranged from 0.8% to 2.0%.
Conclusions: In individuals with suspected ISR after PCI, use of BRS with a down-
stream non-invasive evaluation strategy results in signiﬁcantly lower costs than for
metallic stents evaluated by either invasive or non-invasive methods. In particular, sig-
niﬁcant cost reductions occur when BRS is utilized for PCI and ISR evaluated by CCTA.JACC Vol 64/11/Suppl B j September 13–17, 2014 j TCT Abstracts/VaValvular disease - Aortic: TAVR Imaging
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Background: The transthoracic echocardiographic (TTE) evaluation of the severity of
residual aortic regurgitation (AR) following transcatheter aortic valve implantation
(TAVI) has been controversial and lacks validation. This study sought to compare
TTE and cardiac magnetic resonance (CMR) for assessment of AR in patients un-
dergoing transcatheter aortic valve implantation (TAVI) with a balloon-expandable
valve.
Methods: TTE and CMR exams were performed pre-TAVI in 50 patients and were
repeated post-procedure in 42 patients. All imaging data were analyzed in centralized
core laboratories.
Results: The severity of native AR as determined by multi-parametric TTE
approach correlated well with the regurgitant volume and regurgitant fraction
determined by CMR prior to TAVI (Rs¼0.79 and 0.80, respectively; p< 0.001
for both). However, after TAVI, the correlation between the prosthetic AR
severity assessed by TTE and regurgitant volume and fraction measured by CMR
was only modest (Rs¼0.59 and 0.59, respectively; p< 0.001 for both), with an
underestimation of AR severity by TTE in 61.9% of patients (1 grade in 59.5%).
The TTE jet diameter in parasternal view and the multi-parametric approach
(Rs¼0.62 and Rs¼0.59, respectively; both with p< 0.001) showed the best
correlation with CMR regurgitant fraction post-TAVI. The circumferential extent
of prosthetic paravalvular regurgitation showed a poor correlation with CMR
regurgitant volume and fraction (Rs ¼0.32; p¼0.084; Rs ¼0.36, p¼0.054,
respectively).
Conclusions: The severity of AR following TAVI with a balloon-expandable valve
was underestimated by echocardiography as compared to CMR. The jet diameter, but
not the circumferential extent of the leaks, and the multi-parametric echocardiography
integrative approach best correlated with CMR ﬁndings. These results provide
important insight into the evaluation of AR severity post-TAVI.TCT-665
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Background: Early stent valve thrombosis after transcatheter aortic valve replacement
(TAVR) is a rare complication diagnosed based on the appearance of clinical
symptoms of heart failure and echocardiographic ﬁndings. Following TAVR, trans-
thoracic echocardiography (TTE) is performed to assess transcatheter heart valvelvular disease - Aortic: TAVR Imaging B193
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of multislice computed tomography (MSCT) for the diagnosis of THV thrombosis.
We sought to determine the value of MSCT for the diagnosis of THV thrombosis and
the frequency of this complication after balloon-expandable TAVR.
Methods: In addition to TTE and TEE, MSCT was performed in 140 patients
within 1-3 months after TAVR with the Sapien XT THV (Edwards
Lifesciences, Irvine, CA) to assess the presence of THV thrombosis (distinct
cusp thickening and low attenuation mass) as well as THV stent geometry and
positioning.
Results: Post-TAVR MSCT identiﬁed THV thrombosis in 5 patients (4%), notably 3
(60%) of them had a normal TTE without signs of thrombus formation or ﬂow
obstruction. TOE demonstrated restrictive movement of one or more THV cusps in all
patients, whereas clearly mobile masses were identiﬁed in one patient only. THV
thrombus formation was associated with left ventricular ejection fraction < 35% (60%
vs. 13%; p¼0.021). Neither atrial ﬁbrillation, balloon underﬁlling, THV malposi-
tioning nor THV underexpansion were associated with THV thrombosis (p¼NS for
all). No THVs were noncircular.
Conclusions: THV thrombosis after balloon-expandable TAVR appears to be more
common than previously anticipated and is commonly occult on transthoracic echo-
cardiography. Patients with low-ﬂow circumstances (e.g. depressed cardiac function)
may carry a higher risk of early THV thrombosis. The role of routine post-procedural
MSCT for the evaluation of THV thrombosis in patients at a heightened risk of
thrombus formation warrants further investigation.TCT-666
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transcatheter aortic valve replacements
John Bracken1, Michael S. Kim2, John C. Messenger2, Joseph Cleveland2,
David Fullerton2, Peter Eshuis3, Michael Grass4, John Carroll2
1Philips Research, Briarcliff Manor, NY, 2University of Colorado, Aurora, CO,
3Philips Healthcare, Best, Netherlands, 4Philips Research, Hamburg, Germany
Background: A key step in transcatheter aortic valve replacement (TAVR) pro-
cedures is ﬁnding the optimal x-ray C-arm viewing angle for prosthetic valve
deployment. This step is challenging and often requires performing several 2D x-ray
aortograms. Another approach using short-roll 160 C-arm computed tomography
(C-arm CT) scans was tested on a group of TAVR patients that automatically
reconstructed, landmarked and registered 3D aortic root volumes to efﬁciently
determine this angle.
Methods: Short 160 roll C-arm CT scans were done and reconstructed across 13
TAVR patients under direct contrast injection and rapid ventricular pacing. The
segmented aortic root volume, valve cusp landmarks and optimal viewing angles were
automatically determined from these scans using customized image processing soft-
ware. Optimal angles determined from C-arm CT were compared to angles used
during treatment.
Results: The mean differences between C-arm CT angles and angles used during
deployment were 0.5(SD¼2.6) and 0.5(SD¼2.4)for oblique and cranial/caudal C-
arm angulation respectively. For transapical patients, the angles were easier to obtain
from C-arm CT than unregistered CT due to a rotated patient setup in the cath lab for
better access compared to their baseline CT setup. Transapical unregistered CT mean
angle differences were 18.8(SD¼14.1) and 0.1(SD¼5.2) for oblique and cranial/
caudal angulation.Conclusions: Short roll C-arm CT scans provide accurate optimal viewing angle
estimates at treatment for TAVR patients, along with easier workﬂow compared to the
aortogram approach and to 180(plus fan angle) C-arm CT scans.TCT-667
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Background: Patients with severe aortic stenosis due to BAV are excluded
from transcatheter aortic valve replacement (TAVR) due to concern for
asymmetric expansion and valve dysfunction. We sought to characterize the
aortic root and annulus in bicuspid aortic valve (BAV) and tricuspid aortic
valves (TAV).
Methods: We identiﬁed patients with severe AS who underwent multi-detector
computed tomographic (MDCT) imaging prior to surgical aortic valve replace-
ment (SAVR, n¼200) for BAV and TAVR (n¼200) for TAV from 2010-2013.
The presence of a BAV was conﬁrmed on surgical and pathological review.
Annulus measurements of the basal ring (short- and long-axis, area-derived
diameter), coronary ostia height, sinus area (SA), sino-tubular junction area
(STJ), calciﬁcation and eccentricity index (EI, 1-short axis/long axis) were
made.
Results: Patients with TAV were older (78.8 years vs. 57.8 years, p¼0.04) than
those with BAV. The aortic annulus area (5.21 2.1 cm2 vs. 4.63  2.0 cm2,
p¼0.0001), sinus of Valsalva diameter (3.7  0.9 cm vs. 3.1  0.1 cm, p¼0.001)
and ascending aorta diameter (3.5  0.7 cm vs. 2.97  0.6 cm, p¼0.001) were
signiﬁcantly larger with BAV . Bicuspid aortic annuli were signiﬁcantly less
elliptical (EI, 1.24  0.1 vs. 1.29  0.1, p¼0.006) and more circular (39% vs. 4%,
p < 0.001) compared to the TAV annulus. There was more eccentric annular
calciﬁcation in BAV vs. TAV (68% vs. 32%, p< 0.001). The mean distance from the
aortic annulus to the left main coronary ostium was less than the right coronary
ostium. Less than 10% of the BAV annuli would not ﬁt a currently available valved
stents.
Conclusions: Bicuspid aortic valves have a larger annulus size, sinus of Valsalva and
ascending aorta dimensions. In addition, the BAV aortic annuli appear circular and
most will ﬁt currently available commercial valved stents.
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Background: Transcatheter aortic valve replacement (TAVR) is an approved
treatment for patients at high risk for surgical aortic valve replacement. Computed
tomography angiography (CTA) is essential for pre-procedural planning but patient
with chronic kidney disease (CKD)are at elevated risk for contrast-induced ne-
phropathy (CIN). Minimization of intravenous contrast while obtaining essential
imaging is necessary in this at risk patient population. The accuracy of CTA annular
measurements using a very low dose contrast protocol is unknown. 3-dimensional
transesophageal echocardiography (3D-TEE) annular measurements have been
validated in prior studies and have been the default for TAVR screening in patients
with CKD.
Methods: Patients with severe, symptomatic aortic stenosis and severe CKD
(estimated creatinine clearance < 30 mL/min) and BMI less than 40 kg/m2
underwent full pre-procedural TAVR CTA assessment utilizing a 320-slice
volumetric scanner (Aquilion One, Toshiba Medical Systems) with a 20 cc
contrast bolus injection. One experienced reader measured the aortic annulus on
CTA and measurements were compared to a standard of 3D-TEE, with the latter
being interpreted by one of two experienced readers. CTA and 3D-TEE readers
were different, and were blinded to one another’s measurements. Measurements
were compared using a paired t-test and correlated using Pearson’s correlation
coefﬁcient (R).
Results: 9 patients (average age ¼ 84, BMI ¼ 25 kg/m2, 67% female) who had a 20
cc protocol CTA and 3-D TEE were studied. There was excellent correlation and there
were no signiﬁcant differences in annular measurements between CTA and 3D-TEE
(see Table 1).3–17, 2014 j TCT Abstracts/Valvular disease - Aortic: TAVR Imaging
